Efficacy and safety of colchicine treatment in patients with COVID-19: A prospective, multicenter, randomized clinical trial.
Pourdowlat G, Saghafi F, Mozafari A, Sahebnasagh A, Abedini A, Nabi Meybodi M, Salehi Nezamabadi A, Mousavinasab SR, Kiani A, Raji H, Soltani N, Gholmzadeh Baeis M, Eidani E, Sadeghi Yakhdani A, Movaseghi F, Habtemariam S, Akhoundi Meybodi Z, Gholinataj Jelodar M.
Pourdowlat G, et al. Among authors: mousavinasab sr.
Phytother Res. 2022 Feb;36(2):891-898. doi: 10.1002/ptr.7319. Epub 2022 Feb 2.
Phytother Res. 2022.
PMID: 35107188
Clinical Trial.
Among 202 randomized patients, 153 completed the study and received colchicine/standard care or continued standard care (M age, 54.72 [SD, 15.03] years; 93 [63.1%] men). On day 14, patients in the colchicine/standard care group had significantly higher odds of a better cli …
Among 202 randomized patients, 153 completed the study and received colchicine/standard care or continued standard care (M age, 54.72 …